Topic: risperidone (#risperidone# articles)

Description: Risperidone is a serotonin and dopamine receptor antagonist. It is approved for the treatment of schizophrenia, and is sometimes prescribed as an adjunct therapy for the treatment of aggression, Tourette's syndrome, bipolar disorder, obsessive-compulsive disorder and other disorders. (3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]- 6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one)

Reedsburg man gets 5 months after pleas
******************************
wiscnews - (US) The officer met Newkirk at the park and questioned him about wanting to sell prescription drugs, records state. Newkirk must take alcohol and other drug abuse treatment, register as a sex offender and take other counseling and treatment his probation agent requires. (Wed Nov 18 20:34:46 2009 PST)

Opposing Views: NEWS:Should Medical Marijuana Be Used to Treat Kids With Autism?
******************************
opposingviews - (US) DEA Ignores AMA's New Medical Marijuana Policy Advocacy Group to Sue L.A. if Medical Marijuana Sales are Banned Life in Prison for Growing Marijuana? (Tue Nov 17 10:42:39 2009 PST)

Alkermes Initiates Phase 2 Clinical Study of ALKS 33 for the Treatment of ...
******************************
pharmalive - ALKS 33 is an oral opioid modulator that builds on Alkermes&rsquo. (Tue Nov 17 07:48:38 2009 PST) [also genengnews5092, earthtimes.org8309]

Leerink Swann Upgrades Alkermes (ALKS) to Outperform; Significant Market ...
******************************
streetinsider - StreetInsider.com - Leerink Swann Upgrades Alkermes (ALKS) to Outperform; Significant Market Opportunity in Opioid Dependence StreetInsider.com - Leerink Swann Upgrades Alkermes (ALKS) to Outperform; Significant Market Opportunity in Opioid Dependence Leerink Swann Upgrades Alkermes (ALKS) to Outperform; Significant Market Opportunity in Opioid Dependence Leerink Swann Upg... (Tue Nov 17 05:08:44 2009 PST)

Sam's Story: Medical Marijuana and Autism - KTLA
******************************
ktla - (US) The cannabis was a godsend for Sam's family. (Mon Nov 16 22:19:26 2009 PST)

Phase 3 study of lomitapide (AEGR-733) to lower LDL cholesterol
**************************
empr - Phase 3 study of extended-release injectable naltrexone for treatment of opioid dependence ... (Mon Nov 16 11:34:04 2009 PST)

Alkermes Announces Positive Results from Phase 3 Clinical Study of Naltrexone ...
******************************
pharmalive - Medical treatment for opioid dependence is an established and growing pharmaceutical market. Yet there are limitations with currently available therapies. Multi-center study was designed to assess the efficacy and safety of XR-NTX compared to placebo treatment in opioid dependent subjects who have been recently detoxified and abstinent from opioids for a minimum of seven days prior to treatment initiation. (Mon Nov 16 11:19:52 2009 PST)

more risperidone items (#risperidone# articles)

Links

• http://www.erowid.org/pharms/risperidone/

Concept definition

• risperidone